Abarceo Pharma AB
Developing novel small molecule therapeutics targeting VDAC1 for diabetes.
Overview
- 5–9
- Employees
- 2.5–5M SEK
- Revenue
- 2017
- Founded
Description
Abarceo Pharma is a pre-clinical stage biotechnology company founded in 2017 as a spin-out from the Lund University Diabetes Center. It was established by world-renowned scientists specializing in diabetes research and beta-cell biology. The company has identified Voltage-Dependent Anion Channel 1 (...
Tags
Keywords
Company Information
- Industry
- Bioteknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE559139716001
Decision Makers
No decision makers found yet
Similar Companies
20 similar companies in Funnelfeedr
PILA PHARMA AB
1–4 employeesClinical stage biotech developing an oral obesity and diabetes treatment.
AcroPharma AB (publ)
0 employeesDeveloping innovative preventive therapeutics for major human diseases.
ZEALAND PHARMA A/S
Developing peptide medicines for metabolic health challenges globally.
Oncorena AB
1–4 employeesDeveloping a breakthrough treatment for metastatic renal cancer using orellanine.
NOVO NORDISK SCANDINAVIA AB
100–199 employeesGlobal healthcare leader developing innovative medicines for serious diseases.
Browse More
Abarceo Pharma AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo